Image 4_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 7_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 4_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 5_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 2_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Image 3_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Image 5_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 3_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 9_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 8_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Image 2_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Data Sheet 1_Age and growth of Todaropsis eblanae (Ommastrephidae) through comparison of statoliths, beaks and eye lenses.docx حسب Blondine Agus (10990749)

"…According to a semelparous cycle, the estimated ages for the largest mature female (310-316 days) and male (288-292 days) suggest a lifespan of less than one year. …"

Data Sheet 1_Examining immersive audio’s role in flow and gaze behavior in pseudo-VR environments.docx حسب Quncan Huang (22617845)

"…<p>The audience’s sense of presence diminishes significantly when 360° videos are presented on a flat 2D screen. …"

Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and... حسب Zachary D. Wallen (19986522)

"…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"

Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

"…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"

Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

"…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"

Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

"…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"

Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

"…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"

Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... حسب Zachary D. Wallen (19986522)

"…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …"

Examining cardiac toxicity in HER2-positive breast cancer patients using trastuzumab and its influencing factors at Iran Hospital حسب Fatemeh Nasri (8290011)

"…The criteria for heart failure in this study were defined as an ejection fraction (EF) of less than 50% or a decrease of greater than 10% in EF. …"